Searched for
S D MAZUMDAR
Kiran Mazumdar-Shaw warns against long-term GLP-1 use, urges caution over weight-loss drugs, says 'for those who are not diabetic or clinically obese...'Nithin Kamath questions India's slow adoption of affordable GLP-1 weight-loss drugs, despite rising obesity. He points to challenges like l...- West Bengal's electronics factory push; Fed jitters hit TCSWest Bengal is exploring ways to expand electronics manufacturing under EMC 2.0. This and more in today's ETtech Top 5.
- "Sit down and fix policy...": JPMorgan Chase CEO Jamie Dimon reveals his warning to NYC Mayor Zohran MamdaniJPMorgan CEO Jamie Dimon shared insights from his meeting with NYC Mayor Zohran Mamdani, describing it as pleasant yet direct. Dimon urged ...
- Kiran Mazumdar-Shaw names niece Claire as successor, targets semaglutide push from FY28; debt cut to $1.1 billionBiocon's Executive Chairperson, Kiran Mazumdar-Shaw, outlined a five-year leadership transition with her niece, Claire Mazumdar, as success...
- 'Thank God' Kiran Mazumdar Shaw did not become a doctor: When Dr Devi Shetty shared a life lesson from Biocon founder's inspiring journeyA missed medical college admission propelled Kiran Mazumdar-Shaw towards a different path, ultimately leading to the founding of Biocon. Re...
- Stocks in news: Paytm, Bajaj Auto, L&T, Bharti Airtel, Hero MotoCorpMarkets closed lower amid global headwinds and geopolitical worries. Several companies like Paytm, Bajaj Auto, and L&T are in focus due to ...
- Kiran Mazumdar-Shaw picks niece Claire as successor at BioconBiocon's founder Kiran Mazumdar-Shaw has made a groundbreaking announcement, pledging her niece Claire Mazumdar as her heir apparent. The t...
- The alchemist of Bengaluru: Kiran Mazumdar-Shaw began from a garageKiran Mazumdar-Shaw has named her niece Claire Mazumdar as successor, setting up a gradual leadership transition at Biocon. A pioneer who b...
- Biocon shares rise 1% after billionaire Kiran Mazumdar-Shaw names niece as successorBiocon's chairperson, Kiran Mazumdar-Shaw, has named her niece, Claire Mazumdar, as her successor, sparking a more than 1% jump in the comp...
- Biocon’s Kiran Mazumdar-Shaw chooses niece Claire Mazumdar as successor: ReportBiocon founder Kiran Mazumdar-Shaw has announced her successor. Niece Claire Mazumdar will lead the company. Claire Mazumdar is the founder...
- Claire Mazumdar: A silent force behind a $1.6 billion firm may write Biocon's future scriptsBiocon founder Kiran Mazumdar-Shaw has named her niece, Claire Mazumdar, as her successor. Claire Mazumdar, a successful CEO of Bicara Ther...
- Meet Kiran Mazumdar-Shaw's niece Claire: An MIT grad making Indian innovation shine with $1 billion market debutClaire Mazumdar, CEO of Bicara Therapeutics and niece of Kiran Mazumdar-Shaw, led her company to a successful Nasdaq debut, reaching a mark...
- Kiran Mazumdar-Shaw calls for innovation-driven value creation in India's biotech sectorBiocon Chairperson Kiran Mazumdar-Shaw urges increased investment in research and development to drive innovation and intellectual property...
- D2C skincare brand Foxtale raises $4 million funding led by Matrix Partners IndiaMazumdar previously worked as an investment analyst at A91 Partners, which has backed D2C brands like Sugar Cosmetics and Plum.
- Kiran Mazumdar-Shaw gets lifetime achievement awardBill Gates, co-chair, Bill & Melinda Gates Foundation, gave away this award to Mazumdar-Shaw in New Delhi on Nov 17 at an event to mark the...
- Lift regulations on startups: Kiran Mazumdar-Shaw"Even though the policy sounds very good, there are a lot of hidden regulations in that," she said at a session at the Jaipur Literature Fe...
- Kiran Mazumdar-Shaw ranked no. 2 in power list of UK-based Medicine MakerMazumdar-Shaw has been ranked number two on The Medicine Maker Power List of 2015, an annual list which is compiled by UK-based The Medicin...
- Our Malaysia facility is focussed on insulin & insulin analogues: Kiran Mazumdar Shaw, BioconIt is likely to take some time before we can actually start very aggressively marketing globally from the Malaysia facility.
- Market needs to look at Biocon as a bellwether stock: Kiran Mazumdar Shaw"The biggest problem is that investors do not want us to spend on R&D and R&D is a very integral part of our business."
- GST should be in place by October 2012: CBEC Chairman S D MazumdarDrafting GST legislation on this basis can be done in a month. It would be put in the public domain after due examination and given to the ...
Load More
